NexGel (NXGL) Competitors $2.60 -0.02 (-0.76%) As of 01:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. INO, TELA, EDAP, MLSS, MDAI, SURG, HYPR, NEPH, ICCM, and APTShould you be buying NexGel stock or one of its competitors? The main competitors of NexGel include Inovio Pharmaceuticals (INO), TELA Bio (TELA), Edap Tms (EDAP), Milestone Scientific (MLSS), Spectral AI (MDAI), SurgePays (SURG), Hyperfine (HYPR), Nephros (NEPH), IceCure Medical (ICCM), and Alpha Pro Tech (APT). These companies are all part of the "medical equipment" industry. NexGel vs. Its Competitors Inovio Pharmaceuticals TELA Bio Edap Tms Milestone Scientific Spectral AI SurgePays Hyperfine Nephros IceCure Medical Alpha Pro Tech Inovio Pharmaceuticals (NASDAQ:INO) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations. Which has more risk & volatility, INO or NXGL? Inovio Pharmaceuticals has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Comparatively, NexGel has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. Do analysts prefer INO or NXGL? Inovio Pharmaceuticals currently has a consensus price target of $9.75, indicating a potential upside of 585.17%. Given Inovio Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts plainly believe Inovio Pharmaceuticals is more favorable than NexGel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inovio Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50NexGel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is INO or NXGL more profitable? Inovio Pharmaceuticals has a net margin of 0.00% compared to NexGel's net margin of -30.80%. NexGel's return on equity of -54.95% beat Inovio Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Inovio PharmaceuticalsN/A -136.93% -89.99% NexGel -30.80%-54.95%-27.84% Do institutionals and insiders believe in INO or NXGL? 26.8% of Inovio Pharmaceuticals shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 2.3% of Inovio Pharmaceuticals shares are held by company insiders. Comparatively, 20.6% of NexGel shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger earnings & valuation, INO or NXGL? NexGel has higher revenue and earnings than Inovio Pharmaceuticals. NexGel is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInovio Pharmaceuticals$220K237.19-$107.25M-$3.19-0.45NexGel$8.69M2.29-$3.28M-$0.45-5.78 Does the media prefer INO or NXGL? In the previous week, Inovio Pharmaceuticals had 8 more articles in the media than NexGel. MarketBeat recorded 8 mentions for Inovio Pharmaceuticals and 0 mentions for NexGel. Inovio Pharmaceuticals' average media sentiment score of 0.24 beat NexGel's score of 0.00 indicating that Inovio Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Inovio Pharmaceuticals Neutral NexGel Neutral SummaryInovio Pharmaceuticals beats NexGel on 10 of the 16 factors compared between the two stocks. Get NexGel News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNexGelMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.89M$6.85B$5.49B$9.01BDividend YieldN/A1.16%5.39%4.11%P/E Ratio-5.7826.6227.4320.07Price / Sales2.29100.45397.97109.45Price / CashN/A21.0136.1356.90Price / Book2.894.748.015.67Net Income-$3.28M$173.18M$3.16B$248.47M7 Day Performance8.33%1.65%2.19%2.90%1 Month Performance14.54%0.29%4.49%5.75%1 Year Performance21.50%28.52%35.68%21.39% NexGel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNexGel1.0596 of 5 stars$2.60-0.8%N/A+27.8%$19.89M$8.69M-5.7810INOInovio Pharmaceuticals3.8758 of 5 stars$1.93-1.5%$9.75+405.2%-74.6%$71.88M$220K-0.61320News CoverageGap DownTELATELA Bio3.3186 of 5 stars$1.73+4.8%$7.25+319.1%-58.6%$65.27M$71.22M-1.23120Gap UpEDAPEdap Tms2.363 of 5 stars$1.72+1.3%$8.50+394.2%-70.4%$63.49M$69.18M-2.77230MLSSMilestone Scientific2.6923 of 5 stars$0.80-9.1%$1.25+56.4%-3.7%$62.70M$8.61M-11.4130Gap UpMDAISpectral AI3.0021 of 5 stars$2.05-6.4%$4.75+131.7%+39.8%$55.44M$29.58M-3.8083Analyst RevisionSURGSurgePays3.1983 of 5 stars$2.73+1.1%$9.00+229.7%+1.3%$55.11M$60.88M-0.9840HYPRHyperfine1.8802 of 5 stars$0.690.0%$1.06+52.8%-24.9%$54M$12.89M-1.28190News CoverageNEPHNephros1.0763 of 5 stars$4.29-14.2%$5.00+16.6%+93.2%$53M$15.52M61.2930Gap DownHigh Trading VolumeICCMIceCure Medical2.1143 of 5 stars$0.92-3.3%$2.50+171.7%+36.2%$52.79M$3.29M-3.2960News CoverageGap UpAPTAlpha Pro Tech1.6502 of 5 stars$4.76+0.2%N/A-14.6%$51.60M$58.18M12.86120 Related Companies and Tools Related Companies INO Alternatives TELA Alternatives EDAP Alternatives MLSS Alternatives MDAI Alternatives SURG Alternatives HYPR Alternatives NEPH Alternatives ICCM Alternatives APT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexGel, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexGel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NXGL Stock Alerts